Original language | English |
---|---|
Pages (from-to) | 4972-4973 |
Number of pages | 2 |
Journal | Clinical Cancer Research |
Volume | 20 |
Issue number | 18 |
DOIs | |
Publication status | Published - 15 Sept 2014 |
Externally published | Yes |
Androstenedione is the preferred androgen source in hormone refractory prostate cancer-Response
Christopher Hovens, Matthew Hong, Niall Corcoran
Research output: Contribution to journal › Letter › peer-review
1
Citation
(Scopus)